» Articles » PMID: 28466117

Invasive Hemodynamic Assessment of Patients with Heart Failure and Pulmonary Hypertension

Overview
Date 2017 May 4
PMID 28466117
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Right heart catheterization (RHC) with a pulmonary artery (PA) catheter is a minimally invasive method of obtaining hemodynamic data (e.g., right atrial and pulmonary pressures, cardiac output, pulmonary vascular resistance), which are used to diagnose and manage patients with advanced heart failure (HF), HF with preserved ejection fraction, and pulmonary hypertension (PH). Invasive hemodynamic data obtained from RHC can aid in the prognostication of HF and PH patients and are important in guiding decisions of implanting mechanical circulatory support devices and listing patients for heart and/or lung transplantation. The basis of RHC has also paved the way for implantable hemodynamic devices to monitor pulmonary artery pressures in the outpatient setting, which can reduce rates of HF-related hospitalizations. We will discuss the utility of PA catheters in the diagnosis and management of the aforementioned disease states, the role of implantable hemodynamic monitors, and the complications associated with RHC procedures.

Citing Articles

Assessing Rodent Cardiac Function Using Hemodynamic Pressure-Volume Loops.

Miranda-Silva D, Sequeira V, Lourenco A, Falcao-Pires I Front Physiol. 2022; 12:751326.

PMID: 35811573 PMC: 9260141. DOI: 10.3389/fphys.2021.751326.

References
1.
Iwanaga Y, Nishi I, Furuichi S, Noguchi T, Sase K, Kihara Y . B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol. 2006; 47(4):742-8. DOI: 10.1016/j.jacc.2005.11.030. View

2.
Sitbon O, Humbert M, Jagot J, Taravella O, Fartoukh M, Parent F . Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension. Eur Respir J. 1998; 12(2):265-70. DOI: 10.1183/09031936.98.12020265. View

3.
Opitz C, Hoeper M, Gibbs J, Kaemmerer H, Pepke-Zaba J, Coghlan J . Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum. J Am Coll Cardiol. 2016; 68(4):368-78. DOI: 10.1016/j.jacc.2016.05.047. View

4.
Galie N, Hoeper M, Humbert M, Torbicki A, Vachiery J, Barbera J . Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the.... Eur Heart J. 2009; 30(20):2493-537. DOI: 10.1093/eurheartj/ehp297. View

5.
George M, Champion H, Pilewski J . Lung transplantation for pulmonary hypertension. Pulm Circ. 2011; 1(2):182-91. PMC: 3198646. DOI: 10.4103/2045-8932.83455. View